The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-02-01
DOI
https://doi.org/10.1136/bmjopen-2024-088604
Citations
2
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
3.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial

John A. Smith, A. John Simpson, Ganesh Raghu, Chris Ward et al.
2 citations
BMJ Open
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
3.04
article

The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial

John A. Smith, A. John Simpson, Ganesh Raghu, Chris Ward, Nazia Chaudhuri, David Thickett, Helen Parfrey, Megan Jones, Anthony Cahn, Lisa Spencer, Toby M. Maher, Stephen E. Jones, Shajahan Wahed, Allan Clark, Luke Vale, Andrew M. Wilson, Ian Forrest, Matthew Hammond
article en
2 citations

Abstract

No abstract available for this paper.
BMJ OpenVol. 15(2)
University of East Anglia (GB), University of Southern California (US), University of Ulster (GB), University of Liverpool (GB), GlaxoSmithKline (United Kingdom) (GB), Aintree University Hospitals NHS Foundation Trust (GB), Royal Victoria Infirmary (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), University of Washington Medical Center (US), University of Manchester (GB), Papworth Hospital NHS Foundation Trust (GB), Newcastle upon Tyne Hospital (GB), University of Birmingham (GB), Newcastle University (GB)
Health Technology Assessment Programme
Good health and well-being
Openalex Percentile: Top 11%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.